Position Summary
Senior Scientist (In Vivo Pharmacology, Cell Therapy TRC) responsible for leading discovery and development of novel engineered immune effector cell therapeutics for cancer and other chronic diseases. Will lead functional workstreams from target concept through IND filing, supervise and mentor research associates, and provide scientific/strategic leadership within cross-functional teams.
Position Responsibilities
- Lead in vivo pharmacology workstreams on matrixed cell therapy teams from target concept to IND
- Represent in vivo pharmacology on cross-functional teams; influence decisions and communicate recommendations
- Independently design, execute, and interpret complex in vivo pharmacology studies; determine next steps
- Author scientific documents (presentations, study reports, protocols, publications) and contribute to regulatory and IP filings
- Present complex concepts to governance and departmental audiences
- Integrate literature and emerging technologies to enhance study design
- Supervise/mentor colleagues; ensure technical rigor and execution
- Manage multiple projects in a fast-paced environment; meet deadlines; collaborate effectively
Basic Qualifications
- Bachelorβs + 7+ years (academic/industry)
OR Masterβs + 5+ years
OR Ph.D./equivalent + 2+ years
Preferred Qualifications
- Ph.D. in Immunology/Cancer Biology/Virology or related field; expertise in in vivo immuno-oncology and immune effector cell biology
- 4+ years industry post-degree in immune-based therapies/in vivo immunology/engineered cell therapies
- Advanced murine tumor model development (syngeneic/xenograft/T-cell models) and mechanistic/therapeutic study design; includes combinations
- Familiarity with gene editing and delivery (AAV, non-viral, CRISPR)
Compensation/Benefits (Seattle, WA)
- $136,030β$164,841 (plus potential incentive cash/stock)
- Health coverage, wellbeing support, financial protection; paid time off
Application Instructions
- If the role is of interest but not a perfect resume match, you are encouraged to apply.